Feedback / Questions
allogeneic CAR T-cell therapy - Celyad
"Novartis licenses CAR-T patents from bluebird, Celyad https://t.co/cEbJwnjNcN #biotech $NVS @Novartis"
-
May 9, 2017 -
cmiller1225
Head-to-Head
•
Biosimilar
https://twitter.com/cmiller1225/status/861966576505020417
May 9, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious